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Glycogen Synthase Kinase-3 Modulates
Notch Signaling and Stability
promotes the phosphorylation of the intracellular do-
main of Notch1. We note that an increase in the mobility
of the TM-IC fragment in GSK3 null cells was also
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To examine further the role of GSK3 activity in modu-303 East Chicago Avenue
Chicago, Illinois 60611 lating the phosphorylation of Notch, we next tested the
effect of activated and dominant-negative (DN) forms
of GSK3 [10] on the 32P-phosphate incorporation into
the Notch intracellular domain in neuroblastoma 2aSummary
(N2a) cells (Figure 1B) after transfection with NIC-myc.
A decreased relative amount of 32P was apparent inNotch receptors modulate transcriptional targets fol-
lowing the proteolytic release of the Notch intracellular the Notch1IC band when either the dominant-negative
GSK3 was cotransfected or the cells were treated withdomain (NotchIC). Phosphorylated forms of NotchIC
have been identified within the nucleus [1, 2] and have the GSK3 inhibitor LiCl [11]. The degree of phosphory-
lation was unaffected by transfection of activatedbeen associated with CSL members [3, 4], as well
as correlated with regions of the receptor that are GSK3, suggesting that Notch1IC may already be maxi-
mally phosphorylated in the presence of GSK3 in vivo.required for activity [4, 5]. Genetic studies have sug-
gested that the Drosophila homolog of glycogen syn- Consistent with the evidence of GSK3-dependent
phosphorylation of Notch (presented above), these datathase kinase-3 (GSK3), Shaggy, may act as a posi-
tive modulator of the Notch signaling [6, 7]. GSK3 indicate that GSK3 activity regulates the phosphoryla-
tion of Notch1IC polypeptides in vivo.is a serine/threonine kinase and is a component of the
Wnt/wingless signaling cascade [8]. Here, we ob- The Notch1IC domain is likely to be a direct substrate
for GSK3 phosphorylation because it contains severalserved that GSK3was able to bind and phosphorylate
Notch1IC in vitro, and attenuation of GSK3 activity conserved consensus sites for GSK3, three of which
show a bi- or tripartite site for ordered phosphorylationreduced phosphorylation of NotchIC in vivo. Function-
ally, ligand-activated signaling through the endoge- (S-X3-S-X3-S/T) similar to sites found in glycogen syn-
thase and -catenin [12, 13]. Phosphorylation ofnous Notch1 receptor was reduced in GSK3 null fi-
broblasts, implying a positive role for GSK3 in NotchIC by a serine/threonine kinase such as GSK3
would be consistent with serine phosphorylation of themammalian Notch signaling. As a possible mechanis-
tic explanation of the effect of GSK3 on Notch signal- intracellular domain observed in Drosophila [14]. To test
whether GSK3 was able to directly phosphorylateing, we observed that inhibition of GSK3 shortened
the half-life of Notch1IC. Conversely, activated GSK3 Notch1IC, we prepared a purified glutathione S-trans-
ferase (GST)-Notch1IC fusion and incubated it with re-reduced the quantity of Notch1IC that was degraded
by the proteasome. These studies reveal that GSK3 combinant GSK3. GST-Notch1IC was labeled with a
maximum stoichiometry of 6 mol phosphate per molmodulates Notch1 signaling, possibly through direct
phosphorylation of the intracellular domain of Notch, GST-Notch1IC (Figure 2A). For comparison, the stoichi-
ometry of phosphorylation of purified bovine tau, a sub-and that the activity of GSK3protects the intracellular
domain from proteasome degradation. strate for GSK3 [15, 16], was 1.7 mol phosphate per
mol tau, and GST alone showed only background label-
ing (0.1 mol phosphate per mol protein, data notResults and Discussion
shown).
Furthermore, we observed that Notch and GSK3Phosphorylation of Notch1IC by GSK3
were able to interact directly in vitro. When GSK3 wasIn order to determine whether the activity of GSK3
incubated with GST-Notch1IC in the presence of a largehad an effect on the phosphorylation of Notch1, we
excess of BSA, and complexes were precipitated by thecompared the phosphorylation state of the endogenous
addition of glutathione agarose, GSK3 was found inNotch receptor present in wild-type and GSK3 null
the glutathione agarose pellet (Figure 2B, lane 3). GST-embryonic fibroblasts [9]. The mobility of the endoge-
Notch1IC bound approximately 10% of the input GSK3nous Notch TM-IC fragment from GSK3 null embryonic
(Figure 2B, lane 3 versus lane 4). GSK3was not precipi-fibroblasts was greater than the fragment from wild-type
tated by the glutathione agarose when it was incubatedcells (Figure 1A). Treatment with alkaline phosphatase
alone or with GST (Figure 2B, lanes 1 and 2). Therefore,abolished the difference in the mobility of immunopre-
the intracellular domain of Notch is capable of selec-cipitated Notch TM-IC from wild-type and GSK3 null
tively binding GSK3.cells, suggesting that GSK3 either directly or indirectly
These data reveal that GSK3 activity can affect the
phosphorylation state of NotchIC and that GSK3 is3 Correspondence: jeffrey.s.nye@pharmacia.com
able to bind and phosphorylate NotchIC in vitro. None-4 Present address: CNS Genomics, Pharmacia Corporation, 7242-
209-331.1, 301 East Henrietta Street, Kalamazoo, Michigan 49007. theless, evidence for the direct phosphorylation of
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Figure 2. In Vitro Phosphorylation of GST-Notch1IC by GSK3
(A) GST-Notch1IC was incubated for 1.5 hr with [-32p]ATP and
varying amounts of recombinant GSK3 from 0.1 to 10 units.
(B) Recombinant GSK3 was incubated either alone (lane 1), with
GST (lane 2), or with GST-Notch1IC (lane 3). Proteins bound to GST
or GST-Notch1IC were recovered by incubating the mixtures with
glutathione agarose. For comparison, 1/10 of the amount of GSK3
used in the in vitro binding assay is also shown (lane 4). The presence
of GSK3was detected by immunoblot. Samples were immunoblot-
ted with anti-GST to verify that equal amounts of GST proteins were
present (lower panels).
could indeed regulate one or more of these kinases and
thereby regulate the phosphorylation of NotchIC.
Reduced Notch Signaling in GSK3 Null
Embryonic Fibroblasts
Figure 1. In Vivo Phosphorylation of Notch1IC by GSK3 In order to measure the role of GSK3 in Notch signal
(A) Phosphorylation of endogenous Notch proteins in wild-type and transduction [17], we examined the ability of the endoge-
GSK3 null embryonic fibroblasts was assessed by treating immu- nous Notch receptor to activate the HES1 promoter in
noprecipitates with alkaline phosphatase. In untreated cells, or in
response to its ligand Delta1 in GSK3 null or wild-typethe presence of sodium vanadate (Na3VO4), the endogenous TM-IC
fibroblasts. Embryonic fibroblasts that were wild-typefragment in wild-type cells (gray arrow) shows a greater apparent
molecular weight compared with the TM-IC fragment in GSK3 null or null for GSK3 were transfected with the HES1-Luc
cells (black arrow). In immunoprecipitates treated with alkaline or HES1AB-Luc reporter and were cocultured with QT6
phosphatase in the absence of sodium vanadate, the TM-IC frag- cells expressing either GFP as a control or chick Delta1
ments in wild-type and GSK3 null cells (arrowhead) demonstrate (cDelta1). A statistically significant and reproducible 2.1-
a similar apparent molecular weight.
fold increase in HES1-Luc activity was elicited in wild-(B) NIC-myc was cotransfected into N2a cells with either empty
type cells by Delta1 (Figure 3A), consistent with activa-vector, dominant-negative (DN) GSK3, or activated (Act.) GSK3,
and cells were labeled with [32P]orthophosphate for 4 hr. Indicated tion of the endogenous Notch receptors expressed on
cells were treated with 30 mM LiCl for 18 hr prior to harvesting. these cells (Figure 1A) [18]. However, wild-type cells
(C) The degree of phosphorylation was determined by phosphorim- transfected with a promoter lacking the CBF1-Su(H)-
age analysis and was corrected for differences in protein level by Lag1 (CSL) binding sites (HES1AB-Luc) did not re-
densitometry. The mean degree of phosphorylation was compared
spond to Delta1, revealing that this activation utilizes theamong treatment conditions using ANOVA (an asterisk indicates
CSL family of transcriptional regulators [17]. In contrast,that p  0.05).
cells that lacked GSK3 did not activate the HES1 pro-
moter to a significant degree, suggesting that GSK3 is
required to transduce a Notch signal (Figure 3B).NotchIC by GSK3 in vivo would require the identifica-
tion and mutation of the sites of phosphorylation. Multi- Since prior studies have shown that levels of Notch
can influence the quantity of HES1 activation in cell-ple kinases are likely to play a role in Notch phosphoryla-
tion, as conserved consensus sites for numerous serine/ based assays of Notch signaling [17, 19], we asked if
the differences observed between wild-type and GSK3threonine kinases are distributed within the intracellular
domain of Notch and 32P is incorporated in multiple seg- null cells were a consequence of different levels of
Notch1. No difference in the level of endogenous Notch1ments of the polypeptide as well [4]. Therefore, GSK3
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signaling, and that the reliance of Notch signaling on
GSK3 is greater at lower levels of the Notch receptor
than at higher levels. The partial restoration of Notch
signaling at high Notch levels may reflect a partially
redundant role of a homologous kinase such as GSK3
or the ability of GSK3 to oppose a saturable inhibitory
process. The latter model fits with the evidence provided
(below) that shows that regulation of proteasome-medi-
ated degradation of Notch is a potential mechanism by
which GSK3 influences Notch signaling.
Given that GSK3 null cells were impaired in Notch
signaling, we asked if these cells were able to translo-
cate NotchIC to the nucleus. We therefore transfected
the wild-type and GSK3 null cells with NIC-myc and
examined its subsequent subcellular localization by im-
munofluorescence. The majority of NIC-myc was pres-
ent exclusively within the nucleus in both wild-type and
GSK3 null cells (72% 3% versus 77% 3%, respec-
tively), with the remainder of cells showing both nuclear
and cytoplasmic staining (28% versus 27%). Neither cell
type demonstrated cells that excluded NIC-myc from
the nucleus. Therefore, wild-type and GSK3 null cells
showed no difference in the subcellular localization of
NIC-myc. Moreover, NIC-myc was able to activate the
HES1 promoter in both wild-type and GSK3 null cells
(data not shown). These data reveal that GSK3 does
not control the nuclear localization of NotchIC and imply
that differences in the ability of wild-type and GSK3
null cells to activate the HES1 promoter are not a conse-
quence of changes in the translocation of NotchIC.
Stability of Notch1IC Is Enhanced by GSK3
GSK3 acts within the Wnt/wingless (Wnt/wg) signaling
cascade by altering the stability of two components
of this pathway, -catenin [20–22] and Axin [23]. We
therefore sought to determine if GSK3 influenced the
Figure 3. Delta-Dependent Notch Signaling Is Reduced in GSK3 stability of NotchIC as a possible mechanism underlying
Null Embryonic Fibroblasts
its effects upon Notch signaling. The stability of the
(A and B) (A) Wild-type or (B) GSK3 null embryonic fibroblasts were NotchIC protein was assessed in pulse-chase experi-
transfected with the HES1-Luc or HES1AB-Luc reporter and either
ments with transfected NIC-myc in which GSK3 activitya construct expressing full-length Notch1 (Notch 1-FL) or pCDNA3
was reduced by either cotransfection of DN GSK3 oras a control. Transfected cells were cocultured with QT6 cells ex-
pressing either chick Delta1 (cDelta1) or GFP as a control. Fold by the addition of LiCl (Figure 4A). Untreated NIC-myc
activation was calculated relative to cells that had been transfected was not significantly degraded after 4 hr. In contrast,
with HES1-Luc alone and cocultured with QT6-GFP cells. Values cells treated with either DN GSK3 or LiCl showed a
represent the means of two experiments including three replicates, marked reduction in Notch1IC levels after a 3-hr chase
and error bars represent the SEM. Mean fold activations were com-
(60%  10% and 57%  5%, respectively (n  3); Fig-pared using ANOVA (a double asterisk indicates that p  0.01).
ures 4A and 4B). These experiments indicate that
NotchIC was destabilized by a reduction in GSK3 activ-
ity, suggesting that GSK3 activity serves to stabilizereceptor was observed between wild-type and GSK3
null cells (Figure 1A). Next, we examined GSK3 cells the intracellular domain of Notch, similar to its effects
upon Axin.to see if the observed deficiency in Notch signaling was
influenced by the quantity of Notch expressed. Trans- Notch proteins undergo inactivation by proteasome-
mediated degradation and are regulated by componentsfection of full-length Notch1 into both wild-type and
GSK3 null cells resulted in a greater degree of HES1 of the ubiquitin ligase cascade [24–29]. We therefore
explored whether or not GSK3 activity regulates degra-activation in response to Delta1 stimulation than in un-
transfected cells, which signal through endogenous dation of the NotchIC domain by the proteasome. In
order to determine the role GSK3 plays in the protea-Notch receptors (Figures 3A and 3B). However, after
transfection, Delta1-stimulated HES1 activation in some-mediated degradation of Notch1IC, we compared
the relative abundance of Notch fragments in the pres-GSK3 null cells was still smaller in magnitude than in
wild-type fibroblasts (Figure 3B). These data reveal that ence and absence of the proteasome inhibitors MG132
or lactacystin when NIC-myc and either activated orGSK3promotes but is not absolutely required for Notch
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Figure 4. Inhibition of Endogenous GSK3 Reduces the Stability of NotchIC
(A) Pulse-chase analysis was conducted using N2a cells transiently transfected with NIC-myc and either dominant-negative (DN) GSK3 or
pCDNA3 (control). To inhibit endogenous GSK3, cells were treated with 10 mM LiCl during the pulse and chase periods when indicated.
(B) The amount of 35S-labeled immunoprecipitated protein was quantified and normalized to the values obtained at time zero.
(C) N2a cells transiently expressing NIC-myc were treated for 8 hr with 40 M MG132 or 20 M lactacystin or an equal volume of vehicle
(DMSO and dH2O, respectively). Extracts were blotted with anti-myc to identify expressed Notch1IC protein or with anti--catenin or anti-
tubulin to examine endogenous protein levels in response to proteasome inhibitors.
(D) The effect of GSK3 on the degradation of Notch1IC by the proteasome was assessed by cotransfecting N2a cells with NIC-myc and
either activated (Act.) or dominant-negative (DN) forms of GSK3. Cotransfected cells were treated with 40 M MG132 for 8 hr, as in (C). The
steady-state level of Notch1IC was examined by immunoblotting with anti-myc antibody. The MG132:DMSO ratio was calculated by dividing
the level of steady-state protein observed in MG132-treated conditions by levels observed following treatment with DMSO. Comparisons of
the mean MG132:DMSO between transfection conditions were made using ANOVA (an asterisk indicates that p  0.05).
dominant-negative forms of GSK3 were coexpressed. steady-state protein in cells treated with the proteasome
inhibitor MG132 to control (DMSO-treated) cells (FigureProteasome-mediated degradation of the Notch1IC do-
main was evident in our system, since cells transfected 4D). Activated GSK3 elicited a significant reduction in
the MG132:control ratio from 2.2-fold to 1.2-fold (p with NIC-myc alone and treated with either MG132 or
lactacystin showed higher steady-state levels of NIC- 0.05). The attenuated enhancement of Notch1IC abun-
dance by proteasome inhibitors in the presence of acti-myc than vehicle-treated controls (Figures 4C and 4D).
This was also true for endogenous-catenin, a substrate vated GSK3 provides indirect evidence that GSK3
activity alters the degradation of Notch1IC by the protea-for proteasome-mediated degradation [21, 22], but not
for -tubulin (Figure 4B). In contrast, cells that were some. Thus, the Notch pathway appears to utilize a
mechanism similar to the Wnt/wg pathway for regulatingcotransfected with activated GSK3 failed to show an
increase in the steady-state levels of the intracellular the stability of the active signal. In contrast to the desta-
bilization of-catenin by GSK3phosphorylation, Notchdomain in response to treatment with MG132 or lac-
tacystin (Figure 4D and data not shown). The effect is stabilized by GSK3 activity. Whether the effect of
GSK3 upon proteasome-mediated degradation of Notchof GSK3 on the proteasome-mediated degradation of
Notch1IC was quantitated by determining the ratio of is mediated through the known modulators of Notch
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